Trial
NCT05522387
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Inmune Bio, Inc.
Collaborators
—
Condition
Alzheimer Disease
Intervention
XPro1595
Why stopped
Sponsor resource allocation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-27